Ozempic 0.5 mg injectable solution in a pre-filled pen is a contemporary and successful treatment option for people with type 2 diabetes, helping to enhance their quality of life by properly controlling their disease. It belongs to a family of medications called glucagon-like peptide-1 (GLP-1) receptor agonists.
The pre-filled pen contains a solution of semaglutide, Ozempic’s active component, which is delivered subcutaneously (under the skin). The pen is intended for ease of use, making it a convenient and precise way to administer medication.